Summit Securities Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,500
Closed -$989K 1502
2025
Q1
$989K Buy
+7,500
New +$935K 0.15% 69
2020
Q1
Sell
-100
Closed -$343K 511
2019
Q4
$343K Buy
+100
New +$1.2K 0.03% 323
2019
Q3
Sell
-175
Closed -$227K 437
2019
Q2
$227K Buy
+175
New +$2.24K 0.03% 295

Other funds holding ITCI